UK company launches trial of hallucinogenic drug to treat depression

21st June 2021

, ,

Subscribe to our newsletter

All the latest CBD and Medical Cannabis news, direct to your inbox

By submitting this form, you are giving Canex permission to contact you directly via email. You can opt out at any stage, and your contact data will never be shared with any 3rd party without your explicit consent. View our Privacy Policy.

Keeping subscribers up-to-date with news & insight within the CBD industry. From regulation and legislation reforms, industry updates and guides through the ongoing studies of the substance; to product news, reviews and guides.

Facebook Twitter Linkedin Instagram Youtube

Legal Statements

Canex Platform

Latest Content

Product Reviews

© 2018 - 2024 | Canex Group Ltd | All Rights Are Reserved
All content on this site is intended for educational purposes only. We do not offer healthcare advice in any capacity and you should seek professional medical advice if you are affected by any of the topics covered on this site. All views expressed on this website by interviewees or commentators do not reflect the views of Canex.
Website by Unit Digital